AAPRI Clinical Research Institute

Warwick, Rhode Island 02886

0 studies enrolling now · 7 studies all time

What they study most

Asthma, Atopic Dermatitis, Chronic Cough, Influenza, Influenza A

Studies at this site

• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma — Completed
• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications — Stopped early
• Evaluation of S-600918 in Adults With Refractory Chronic Cough — Completed
• A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA) — Completed
• GB001 in Adult Subjects With Moderate to Severe Asthma — Completed
• Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza — Completed